Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Semapimod suggested to be effective in Crohn's disease

June 1, 2004

Pharmacokinetics and safety of fontolizumab in Crohn's disease

June 1, 2004

Therapeutic benefits of cilansetron in IBS

June 1, 2004

Update on natalizumab in Crohn's disease

June 1, 2004

Pioglitazone improves features of nonalcoholic steatohepatitis

May 28, 2004

Renzapride improves bowel function and reduces abdominal pain/discomfort in IBS

May 28, 2004

BPC-157 reported to promote ulcer healing in rats

May 28, 2004

Visilizumab found effective in refractory ulcerative colitis

May 28, 2004

Benefits associated with IB-MECA in a model of experimental colitis

May 27, 2004

Vertex plans METRO study for merimepodib

May 27, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...